|
GB9905136D0
|
|
Surface modification of lamellar particles
|
|
GB9904627D0
|
|
Polymer compositions for polynucleotide delivery
|
|
GB9904629D0
|
|
Oral drug delivery system
|
|
GB9828861D0
|
|
Compositions
|
|
GB9823246D0
|
|
A nasal drug delivery composition
|
|
GB9818591D0
|
|
Pharmaceutical composition
|
|
GB9817650D0
|
|
Oral formulation
|
|
GB9805253D0
|
|
Nasal formulation
|
|
GB9801363D0
|
|
Novel dosage form
|
|
GB9800912D0
|
|
New composition
|
|
GB9726916D0
|
|
Nasal formulation
|
|
GB9725519D0
|
|
Nasal formulation
|
|
GB9724786D0
|
|
Oral delivery system
|
|
GB9718986D0
|
|
Controlled release microsphere delivery system
|
|
GB9715759D0
|
|
New emulsion formulations
|
|
GB9900048D0
|
|
Compositions suitable for delivery of genes to epithelial cells
|
|
GB9713980D0
|
|
New conjugates
|
|
GB9710699D0
|
|
Gastro-retentive controlled release system
|
|
GB9707934D0
|
|
Improved delivery of drugs to mucosal surfaces
|
|
GB9700624D0
|
|
Drug delivery composition
|
